donderdag 29 mei 2014
Reboxetine (brand names: Edronax, Prolift) is a drug of the norepinephrine reuptake inhibitor class, marketed as an antidepressant by Pfizer for use in the treatment of unipolar depression.
Although it has also been used off-label for panic disorder and ADHD.
It is approved for use in many countries worldwide, but has NOT been approved for use in the United States. Although its efficacy as an antidepressant has been challenged in multiple published reports, its popularity has continued to increase.
Ontwikkeld in en getest op dieren.